AUA2017 Webcasts

Plenary Webcasts supported by independent educational grants from:

  • Astellas
  • Merck
  • Olympus Corporation of the Americas

Prime Time Sunday Morning

Late-Breaking Abstract - Quality of Life after Penile Prosthesis Implantation – 1 year follow-up Data of the Italian Prospective Registry INSIST-ED

Speaker: Paolo Capogrosso, MD

Play Video 2   Play Video 1 ESP  


Next Frontier Sunday Morning

Late-Breaking Abstract: Current Anti-Retroviral Treatments Do Not Eliminate HIV From Semen

Speaker: Robert C. Eyre ,MD

Play Video 2   Play Video 1 ESP  


Late-Breaking Abstract - A Head To Head Comparative Phase II Trial of Standard Urine Culture and Sensitivity versus DNA Next Generation Sequencing Testing for Urinary Tract Infections

Speaker: Michael William McDonald MD

Play Video 1   Play Video 2 ESP  


Next Frontier Sunday Afternoon

Late-Breaking Abstract - WATER Study Clinical Results - Phase III double-blind randomized control trial of Aquablation vs. Transurethral Resection of the Prostate for Moderate-to-Severe Benign Prostatic Hyperplasia

Speaker: Claus G. Roehrborn, MD

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Randomized Clinical Trial of Treatment with Tamsulosin Begun in the Emergency Department to Promote Passage of Urinary Stones

Speaker: Andrew Meltzer

Play Video 2   Play Video 1 ESP  


Late-Breaking Abstract - Polyurethanes for Urinary Stents: A Study on Materials’ Stone Encrustation Performances

Speaker: Gary Li

Play Video 2   Play Video 1 ESP  


Late-Breaking Abstract - The Impact of Scribes on Office Productivity in Urology Practice

Speaker: Deepak A. Kapoor, MD

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Bladder Injury Activates Innate Immunity During Short-term Foley Catheterization in a Swine Model

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Is Group Learning Behavioral Modification Program Effective and Safe in Reducing Geriatric Urinary Incontinence? A Multi-Center Randomized Controlled Trial

Speaker: Ananias C. Diokno, MD

Play Video 2   Play Video 1 ESP  


Prime Time Sunday Afternoon

Late-Breaking Abstract - Blue Light Flexible Cystoscopy (BLFC) with Hexaminolevulinate (HAL) and White Light Flexible Cystoscopy: A Prospective, Comparative, Within-Patient Controlled Multi-Center Phase 3 Study in the Detection of Bladder Cancer during Surveillance

Speaker: Siamak Daneshmand, MD

Play Video 2   Play Video 1 ESP  


Next Frontier Sunday Afternoon

Late-Breaking Abstract - Long-term Combination Treatment with Solifenacin and Mirabegron is Effective and Well Tolerated in Patients with Overactive Bladder

Speaker: Christian Gratzke, MD

Play Video 2   Play Video 1 ESP  


Next Frontier Monday Morning

Late-Breaking Abstract - A Phase III Blinded Study of Immediate Post-TURBT Instillation of Gemcitabine versus Saline in Patients with Newly Diagnosed or Occasionally Recurring Grade I/II Non-Muscle Invasive Bladder Cancer: SWOG S0337

Speaker: Edward M. Messing, MD

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Radical Prostatectomy versus Observation for Early Prostate Cancer: Follow-up Results of the Prostate Cancer Intervention versus Observation Trial

Speaker: Timothy J. Wilt, MD

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)

Speaker: Mohammad R. Siddiqui

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Interim Results from A Single-Arm Multicenter Phase II Trial of CG0070, an Oncolytic Adenovirus, for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer (NMIBC)

Speaker: Vignesh Packiam ,MD

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Early In Vivo Detection of Metastatic Bladder Cancer in Mice using Molecular MRI

Speaker: Joel Wilson Slaton, M.D.

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Interim Results of a Novel ‘Adaptive’ Registration-Utility Trial Assessing the Performance of Exodx® (Prostate) Intelliscore (EPI); a Non-DRE Urine Exosome Gene Expression Assay to Predict High Grade Disease on Initial Biopsy

Speaker: Alan W. Partin, MD

Play Video 2   Play Video 1 ESP  


Late-Breaking Abstract - First results of A-PREDICT: A Phase II Study of Axitinib in Patients with Metastatic Renal Cell Cancer (RCC) Unsuitable for Nephrectomy

Speaker: Grant Stewart

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - Detection of Circulating Tumor Cell in the Patients with Prostate Cancer Using Novel Viral Marker OBP-1101

Speaker: Nobuyuki Hinata

Play Video 1   Play Video 2 ESP  


Late-Breaking Abstract - A Prospective, Multicenter, Randomized Trial of Open versus Robotic Radical Cystectomy (RAZOR)

Speaker: Dipen J. Parekh, MD

Play Video 2   Play Video 1 ESP